World CML Day 2026 takes place on September 22. This year marks 25 years of medical progress since the first targeted therapy transformed chronic myeloid leukemia treatment. The date 9/22 represents the genetic translocation of chromosomes 9 and 22 that causes CML. The theme for 2026 is “From Access to Monitoring: 25 Years Forward For Every CML Patient.”
This year celebrates a quarter-century of life-changing tyrosine kinase inhibitors (TKIs) that turned a fatal diagnosis into a manageable chronic condition. World CML Day is a global voice uniting patients, caregivers, families, and medical professionals.
Here is the latest CML news found on HealthTree:
FDA Approves New Immunotherapy To Improve Stem Cell Transplant Success In Blood Cancer Patients
On June 30, 2026, the U.S. Food and Drug Administration (FDA) approved a groundbreaking new cell therapy called Tregzi (T cells-vldq), developed by Orca Bio. This therapy is designed for adults with blood cancers (like leukemia or myelodysplastic syndrome) who are undergoing a stem cell transplant from a matched donor. Tregzi aims to help rebuild the immune system safely while dramatically lowering the risk of long-term complications known as chronic graft-versus-host disease (GVHD).
What High Neutrophils May Mean For People with Cancer
Neutrophils are a type of white blood cell. They help the body fight infections caused by bacteria and fungi. Doctors often check neutrophil levels during a complete blood count (CBC). A CBC measures white blood cells, red blood cells, and platelets. A high neutrophil count is called neutrophilia.
High neutrophils usually mean the body is responding to stress, inflammation, or infection. Inflammation is the body’s response to injury or irritation. Cancer causes the bone marrow to produce an uncontrolled number of these cells.
Coping With Cancer: Mental Health Tips & Tools With Dr. Megan Dwyer (Event Recording)
A cancer diagnosis can feel overwhelming and affect every part of life, including your mental and emotional well-being, but you don’t have to face it alone. In this webinar, Dr. Dwyer shares practical, compassionate strategies to help patients and caregivers manage stress, anxiety, and the emotional challenges that come with cancer.
Peripheral Neuropathy: What People With Cancer Need To Know
Neuropathy is a general term for a condition that affects the nerves. Peripheral neuropathy refers to any damage affecting the nerves outside of the brain or spinal cord. Neuropathy can feel like numbness, tingling, weakness, burning, or pain. It most often starts in the hands or feet. Neuropathy is very common in people with cancer. Research shows that 30-40% of people with cancer experience some form of neuropathy.
Better Sleep With Cancer: Understanding Sleep Problems and How To Rest Better
Sleep plays a vital role in physical health, emotional balance, and recovery. It is a biological necessity for people to function properly. For people with cancer, sleep is an important part of overall health. In this article, you’ll learn how sleep can help you recover, how sleep disorders affect people with cancer and their caregivers, and how to improve sleep hygiene and sleep quality.
A New Target In TP53-Mutated Blood Cancers: Could Blocking PLEK2 Slow Disease Progression?
Changes to the TP53 gene are common in many blood cancers. This mutation can make people face more challenges with the therapies they receive. Researchers are working to understand the changes in cells when TP53 mutations are present. A new study highlights how this mutation affects a protein called PLEK2, and how this protein may be a promising target that may help slow disease progression in high-risk patients.
Can Genetic Information Present At Diagnosis Predict Relapse And Shape CML Treatment Planning?
Certain genetic characteristics of chronic myeloid leukemia (CML) can predict the likelihood that relapse will occur. Relapse is when the cancer comes back after treatment ends. Being able to understand a patient’s risk of relapse at the time of diagnosis can help doctors evaluate what treatments will be most effective for treating CML.
CML occurs when genetic changes produce an enzyme called tyrosine kinase that promotes excessive growth of white blood cells. A type of targeted therapy called tyrosine kinase inhibitors (TKI) is the main treatment for CML. It works by blocking tyrosine kinase enzymes and helping to stop the growth of cancer cells.
Conclusion
As we recognize World CML Day 2026, we celebrate 25 years of remarkable progress that have changed the outlook for people living with chronic myeloid leukemia. Future progress depends on every patient having access to effective treatment, regular monitoring, accurate information, and emotional support. On this World CML Day, let’s take the opportunity to see how far CML care has come and also look forward to a future where every person with CML has the chance to live a longer and healthier life.
Keep track of your health with HealthTree
Navigating a multiple myeloma diagnosis is easier when you have access to personalized tools, trustworthy education, and a supportive community. The HealthTree Foundation offers free resources to empower patients and caregivers at every step:
